UK Lambert Toolkit, Model Consortium Agreement A Post author:GHIAA Admin Post published:March 13, 2025 Post category: Continue ReadingUK Lambert Toolkit, Model Consortium Agreement A
Roche – PTC Therapeutics – Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement Post author:GHIAA Admin Post published:December 10, 2024 Post category: Continue ReadingRoche – PTC Therapeutics – Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
Spinal Muscular Atrophy Foundation – PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement Post author:GHIAA Admin Post published:November 22, 2024 Post category: Continue ReadingSpinal Muscular Atrophy Foundation – PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
Gilead, HIV Therapeutic (Lenacapavir) Template License Agreement Post author:GHIAA Admin Post published:October 23, 2024 Post category: Continue ReadingGilead, HIV Therapeutic (Lenacapavir) Template License Agreement
Novartis – MPP, Nilotinib, Non-Exclusive License Agreement Post author:GHIAA Admin Post published:October 17, 2024 Post category: Continue ReadingNovartis – MPP, Nilotinib, Non-Exclusive License Agreement
MPP – Biovac, mRNA Vaccine Technology Transfer Agreement Post author:GHIAA Admin Post published:October 8, 2024 Post category: Continue ReadingMPP – Biovac, mRNA Vaccine Technology Transfer Agreement
Gates Foundation – Amyris, Inc., Malaria Therapeutic (artemisinin-based combination therapies – ACTs), Letter Agreement Post author:GHIAA Admin Post published:September 12, 2024 Post category: Continue ReadingGates Foundation – Amyris, Inc., Malaria Therapeutic (artemisinin-based combination therapies – ACTs), Letter Agreement
CEPI – University of Oxford – Barinthus Biotherapeutics, ChAdOx1 MERS Vaccine R&D Funding Agreement Post author:GHIAA Admin Post published:September 2, 2024 Post category: Continue ReadingCEPI – University of Oxford – Barinthus Biotherapeutics, ChAdOx1 MERS Vaccine R&D Funding Agreement
Adjuvant Global Health Technology Fund – AN2 Therapeutics, Melioidosis & Tuberculosis Therapeutic (Epetraborole) Global Health Agreement Post author:GHIAA Admin Post published:August 26, 2024 Post category: Continue ReadingAdjuvant Global Health Technology Fund – AN2 Therapeutics, Melioidosis & Tuberculosis Therapeutic (Epetraborole) Global Health Agreement